BioCentury
ARTICLE | Top Story

Syndax raises $26.6 million in series B

August 27, 2013 11:55 PM UTC

Cancer company Syndax Pharmaceuticals Inc. (Waltham, Mass.) raised $26.6 million in a series B round from existing investors Domain Associates; MPM Capital; and Forward Ventures as well as new investo...